Back to Journals » Journal of Asthma and Allergy » Volume 11

Economic considerations in the treatment of systemic allergic reactions

Authors Westermann-Clark E, Pepper AN, Lockey RF

Received 14 December 2017

Accepted for publication 17 March 2018

Published 20 June 2018 Volume 2018:11 Pages 153—158

DOI https://doi.org/10.2147/JAA.S159851

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Ms Justinn Cochran

Peer reviewer comments 3

Editor who approved publication: Dr Amrita Dosanjh


Emma Westermann-Clark,1,2 Amber N Pepper,1,2 Richard F Lockey1,2

1Division of Allergy and Immunology, Department of Internal Medicine, University of South Florida Morsani College of Medicine, 2James A. Haley Veterans Affairs Hospital, Tampa, FL, USA

Abstract:
Epinephrine is a life-saving medication used to treat systemic allergic reactions including anaphylaxis. Epinephrine autoinjectors (EAIs) are expensive and worldwide availability is limited. Epinephrine prefilled syringes and epinephrine kits are potentially lower-cost alternatives to EAIs. Advantages, disadvantages, and costs of available products are discussed. The socioeconomic factors impacting access to EAIs are described.

Keywords: epinephrine, anaphylaxis, cost, price, autoinjector

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]